Pac1 (Adcyap1R1) Receptor [Neurons](/entities/neurons) is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Pituitary adenylate cyclase-activating polypeptide (PACAP) receptor 1 (PAC1R, ADCYAP1R1) neurons express the PAC1 receptor, a G protein-coupled receptor that binds both PACAP and vasoactive intestinal peptide (VIP). PAC1R is a critical neuropeptide receptor involved in neuroprotection, synaptic plasticity, circadian rhythm regulation, and stress responses throughout the central nervous system. [@pacap2021]
Molecular Biology
Gene and Receptor Structure
The ADCYAP1R1 gene (located on chromosome 7p14) encodes the PAC1 receptor, a class B GPCR with: [@pacr2019]
Pac1 (Adcyap1R1) Receptor [Neurons](/entities/neurons) is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Pituitary adenylate cyclase-activating polypeptide (PACAP) receptor 1 (PAC1R, ADCYAP1R1) neurons express the PAC1 receptor, a G protein-coupled receptor that binds both PACAP and vasoactive intestinal peptide (VIP). PAC1R is a critical neuropeptide receptor involved in neuroprotection, synaptic plasticity, circadian rhythm regulation, and stress responses throughout the central nervous system. [@pacap2021]
Molecular Biology
Gene and Receptor Structure
The ADCYAP1R1 gene (located on chromosome 7p14) encodes the PAC1 receptor, a class B GPCR with: [@pacr2019]
Extracellular N-terminal domain: Contains PACAP/VIP binding site
Seven transmembrane domains: G protein coupling
Intracellular loops: Signal transduction machinery
C-terminal tail: Phosphorylation sites for desensitization
Novel analogs: BBB-penetrant compounds in development
Clinical Status
Phase I trials for stroke (completed)
Phase II for AD (ongoing)
Orphan drug status for ALS
Delivery Challenges
BBB penetration: Limited by peptide nature
Peptidase degradation: Short half-life
Receptor desensitization: Downregulation with chronic use
Research Methods
Molecular Techniques
ADCYAP1R1 knockout mice
siRNA/shRNA knockdown
CRISPR gene editing
Electrophysiology
Whole-cell patch clamp
Field potential recordings
Calcium imaging
Behavioral Tests
Morris water maze
Open field
Circadian activity monitoring
Background
The study of Pac1 (Adcyap1R1) Receptor Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
The following diagram shows the key molecular relationships involving PAC1 (ADCYAP1R1) Receptor Neurons discovered through SciDEX knowledge graph analysis: